WAVE Life Sciences Ltd Stock
Price
Target price
€15.20
€15.20
7.800%
1.1
7.800%
€18.37
23.12.25 / Stuttgart Stock Exchange
WKN: A1436W / Symbol: WVE / Name: WAVE Life / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
WAVE Life Sciences Ltd Stock
WAVE Life Sciences Ltd dominated the market today, gaining €1.10 (7.800%).
With 20 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 18 € there is a slightly positive potential of 18.42% for WAVE Life Sciences Ltd compared to the current price of 15.2 €.
So far the community has only identified positive things for WAVE Life Sciences Ltd stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of WAVE Life Sciences Ltd in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of WAVE Life Sciences Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| WAVE Life Sciences Ltd | 7.800% | 10.949% | 130.303% | 18.750% | 24.590% | 218.191% | 115.603% |
| Intellia Therapeutics Inc | -2.110% | 1.039% | 3.422% | -30.596% | -29.802% | -75.388% | -84.006% |
| Protalix Biotherapeutics Inc. | 4.730% | 2.013% | -3.797% | -12.694% | -13.930% | 34.335% | -48.299% |
| Arbutus Biopharma Corp. | 1.910% | 4.910% | 4.689% | 28.859% | 31.328% | 77.569% | 33.850% |
Comments
WAVE Life Sciences (NASDAQ:WVE) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Show more
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Show more
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) was given a new $50.00 price target on by analysts at Truist Financial Corporation. They now have a "buy" rating on the stock.
Show more
Ratings data for WVE provided by MarketBeat